SEC Form 4 · accession 0001615774-17-003707
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Smith
Director
Period of report
Nov 7, 2016
Accepted (ET)
Jul 18, 2017 · 8:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 14, 2017 | A | 25,000 | $0.00 | A | 115,526 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $6.00 | Nov 7, 2016 | A | 8,000 | A | Nov 7, 2016 | Sep 22, 2026 | Common Stock | 8,000 | 24,000 | D |
| Employee Stock Option (right to buy)F2 | $6.00 | Jul 14, 2017 | A | 8,000 | A | Jul 14, 2017 | Sep 22, 2026 | Common Stock | 8,000 | 32,000 | D |
Explanation of responses
- F1The registrant agreed to pay the associated taxes, federal and state, for this award.
- F2On September 22, 2016, the reporting person was granted an option to purchase 40,000 shares of common stock. The option vests in five equal installments based on the reporting person's satisfaction of certain performance criteria. As previously reported, the performance criteria for the first and second installments were met, resulting in the vesting of the option as to 16,000 shares. On November 7, 2016 and July 14, 2017, the performance criteria for the third and fourth installments, respectively, were met, resulting in the vesting of the option as to 8,000 shares on each of the aforementioned dates.